3 Growth Stocks That Could Go Parabolic in 2024
These innovation-oriented companies could take flight this year.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Taysha Gene Therapies, Inc. (NASDAQ: TSHA) for Potential Breaches of Fiduciary Duty By Its Board of Directors
/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...
2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?
These highly volatile stocks recently rocketed higher, but what are the chances that they'll be able to provide further gains?
S&P Futures Tick Lower As Investors Await Fed Rate Decision, Snap Plunges on Weak Outlook
March S&P 500 futures (ESH23) are trending down -0.41% this morning after three major U.S. benchmark indices finished the regular session higher as market participants weighed up economic data and a slew...
Taysha Gene Therapies (NASDAQ: TSHA) Receives $50 Million Strategic Investment From Astellas Pharma to Develop AAV-Based Gene Therapeutics
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is a biotechnology company that is focused on developing gene therapies to treat monogenic